Temperature questions and answers
1.
What should I do if the product is left out at room temperature?
Expiration dates for refrigerated (before first use) product and in-use times for room temperature (after first use) product are based on proprietary data generated by Novo Nordisk and approved by regulatory authorities, such as the Food and Drug Administration (FDA), to ensure that potency of properly handled product is maintained while the product is in use. The FDA allows manufacturers to issue timelines that ensure the longest in-use time without sacrificing potency.
Please refer to the individual Novo Nordisk products regarding recommended storage times and temperatures.
2.
What should I do if the product is exposed to frozen temperatures?
To prevent loss of potency, clumping, frosting, or precipitation, Novo Nordisk products should not be frozen (below 36 °F or 2 °C). Do not use products exposed to frozen temperatures.
3.
What should I do if the product is exposed to high temperatures?
Storage at high temperatures above 86 °F or above 30 °C should be avoided for all Novo Nordisk products. Do not use if products are exposed to temperatures above 86 °F (30 °C). The product should be inspected for changes such as clumping, precipitation, or change in color or clarity that may indicate a loss in potency.
Find more information
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
